ID: ALA3604556

Max Phase: Preclinical

Molecular Formula: C22H31N10O18P3

Molecular Weight: 816.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[n+]1cn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4c[n+](C)c5c([O-])nc(N)nc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c2nc(N)nc([O-])c21

Standard InChI:  InChI=1S/C22H31N10O18P3/c1-29-5-31(15-9(29)17(37)27-21(23)25-15)19-13(35)11(33)7(47-19)3-45-51(39,40)49-53(43,44)50-52(41,42)46-4-8-12(34)14(36)20(48-8)32-6-30(2)10-16(32)26-22(24)28-18(10)38/h5-8,11-14,19-20,33-36H,3-4H2,1-2H3,(H7-2,23,24,25,26,27,28,37,38,39,40,41,42,43,44)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1

Standard InChI Key:  XHWOIYZXNKJMSK-XPWFQUROSA-N

Associated Targets(non-human)

Eukaryotic translation initiation factor 4E 100 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 816.46Molecular Weight (Monoisotopic): 816.1031AlogP: -5.56#Rotatable Bonds: 12
Polar Surface Area: 415.54Molecular Species: ACIDHBA: 23HBD: 9
#RO5 Violations: 3HBA (Lipinski): 28HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.82CX Basic pKa: 2.13CX LogP: -12.57CX LogD: -16.04
Aromatic Rings: 4Heavy Atoms: 53QED Weighted: 0.05Np Likeness Score: 0.69

References

1. Ziemniak M, Kowalska J, Lukaszewicz M, Zuberek J, Wnek K, Darzynkiewicz E, Jemielity J..  (2015)  Phosphate-modified analogues of m(7)GTP and m(7)Gppppm(7)G-Synthesis and biochemical properties.,  23  (17): [PMID:26264844] [10.1016/j.bmc.2015.07.052]

Source